• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Arbutus Biopharma

Focus on legal hammer
Pharma

Arbutus, Genevant expand COVID patent feud with Moderna

The companies claim that Moderna stepped on their lipid nanoparticle technology with its COVID vaccine Spikevax and RSV vaccine mRESVIA.
Zoey Becker Mar 4, 2025 11:49am
Patents on file

Arbutus, Genevant nab a pre-trial edge in Moderna patent suit

Apr 4, 2024 10:48am
Blurred image of judge striking a gavel gorodenkoffGetty Images

Court upholds prior strike of Arbutus patent in Moderna case

Apr 12, 2023 11:44am
Patents on file

Arbutus, Genevant claim Pfizer patent infringement in new suit

Apr 4, 2023 11:48am
Blurred image of judge striking a gavel gorodenkoffGetty Images

Moderna's motion to dismiss patent suit denied by federal judge

Nov 3, 2022 4:23pm
CureVac

CureVac sues BioNTech for infringement on its mRNA technology

Jul 5, 2022 9:21am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings